Common Stock
- Symbol
- CRVO
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 7.01, 8.01, 9.01 · 8-K
CervoMed Inc.
CRVONASDAQEQUITYCurrent
Regulation FD Disclosure · Other Events
Item 7.01. Regulation FD Disclosure. On September 28, 2026, CervoMed Inc. (the “Company”) issued a press release announcing pharmacokinetic, regulatory, and manufacturing updates related to its lead drug candidate, neflamapimod. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.…
Recent company filings
- Regulation FD Disclosure · Other EventsOct 13, 2026
- Regulation FD DisclosureOct 9, 2026
- Regulation FD Disclosure · Other EventsSep 10, 2026
- SCHEDULE 13G/A - filed by RA CAPITAL MANAGEMENT, L.P. regarding CervoMed Inc.Aug 14, 2026
- SCHEDULE 13G/A - filed by CVI Investments, Inc. regarding CervoMed Inc.Aug 14, 2026
Registered securities in this filing
CervoMed Inc. · 8-K · Filed 2026-09-28
Disclosure sections
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
On September 28, 2026, CervoMed Inc. (the “Company”) issued a press release announcing pharmacokinetic, regulatory, and manufacturing updates related to its lead drug candidate, neflamapimod. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
The press release, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K, is incorporated herein by reference. The information in or incorporated by reference into this Item 7.01 and Exhibit 99.1 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 8.01Item 8.01 - Other Events
Item 8.01. Other Events.
The information set forth in the first and second paragraphs of, and under the heading “Supporting Data and Details” in, the Company’s press release on September 28, 2026, is incorporated by reference into this Item 8.01 of this Current Report on Form 8-K.